In the 40-some years since the beginning of the HIV/AIDS epidemic, scientists have learned a lot about the virus, the disease, and ways to treat it. But one thing they still don't completely understand is exactly which cells ...
Apr 27, 2021
0
21
Researchers from Wake Forest School of Medicine in North Carolina have demonstrated that a common diabetes drug inhibits the spread of Clostridioides difficile, or C. diff—a potentially life-threatening infection commonly ...
Apr 27, 2021
0
39
When a new drug is being developed, the first question is, "Does it work?" The second question is, "Does it do harm?" No matter how effective a therapy is, if it harms the patient in the process, it has little value.
Apr 8, 2021
0
1
A living biobank could support the development of new therapies for advanced ovarian cancer. Here we follow the journey of a Cancer Research UK-funded team to build a living biobank for ovarian cancer.
Mar 29, 2021
0
3
Many big pharma companies were able to roll out vaccines against SARS-CoV-2 in record time by retooling their existing experimental mRNA gene therapies to carry a new payload. Whereas these cancer vaccines originally coded ...
Researchers at the University of Florida collected the SARS-CoV-2 virus which causes COVID-19 from the air within a car driven for 15 minutes by a patient confirmed to have the illness. The driver had minimal symptoms, without ...
Feb 24, 2021
0
25
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...
Feb 10, 2021
0
141
Reports of new variants of the SARS-CoV-2 coronavirus have become more frequent in the last few weeks. Richard Neher researches the evolution of viruses and bacteria at the Biozentrum of the University of Basel. From 2011 ...
Feb 2, 2021
0
2
Building on the promise of emerging therapies to deploy the body's natural killer immune cells to fight cancer, researchers at the University of Michigan Rogel Cancer Center and U-M College of Engineering have gone one step ...
Jan 28, 2021
0
285
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Jan 25, 2021
0
39
